FDA ▶ Regulatory submissions

A Study of Tirzepatide in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (2021)

  Back

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602a22c2678e12ed257f532_Eli_Lilly_and_Company.svg.png

https://clinicaltrials.gov/study/NCT04847557

Read also



Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (2019)
FDA
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (2019)
READ MORE →
 Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (2023)
FDA
Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (2023)
READ MORE →
 Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (2019)
FDA
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (2019)
READ MORE →
 CardiAMP™ Cell Therapy for Heart Failure Trial (2016)
FDA
CardiAMP™ Cell Therapy for Heart Failure Trial (2016)
READ MORE →